Stem Cells Spin (WAR:SCS) Change In Receivables : zł0.13 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Stem Cells Spin Change In Receivables?

Stem Cells Spin's change in receivables for the quarter that ended in Dec. 2024 was zł0.01 Mil. It means Stem Cells Spin's Accounts Receivable declined by zł0.01 Mil from Sep. 2024 to Dec. 2024 .

Stem Cells Spin's change in receivables for the fiscal year that ended in Dec. 2024 was zł0.13 Mil. It means Stem Cells Spin's Accounts Receivable declined by zł0.13 Mil from Dec. 2023 to Dec. 2024 .

Stem Cells Spin's Accounts Receivable for the quarter that ended in Dec. 2024 was zł0.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Stem Cells Spin's Days Sales Outstanding for the three months ended in Dec. 2024 was 25.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Stem Cells Spin's liquidation value for the three months ended in Dec. 2024 was zł-3.81 Mil.

Stem Cells Spin Change In Receivables Historical Data

The historical data trend for Stem Cells Spin's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Cells Spin Change In Receivables Chart

Stem Cells Spin Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

0.05

-0.11

0.05

0.13

Stem Cells Spin Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-0.13	0.13	-	-	0.01

Stem Cells Spin Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.13 Mil.

Stem Cells Spin (WAR:SCS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Stem Cells Spin's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.014	/	0.05	*	91
=	25.55

2. In Ben Graham's calculation of liquidation value, Stem Cells Spin's accounts receivable are only considered to be worth 75% of book value:

Stem Cells Spin's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.003	-	4.116	+	0.75 * 0.014	+	0.5 * 0.591
=	-3.81

Stem Cells Spin Change In Receivables Related Terms

Thank you for viewing the detailed overview of Stem Cells Spin's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Stem Cells Spin Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stem Cells Spin SA (WAR:SCS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141

Website

http://stemcellsspin.com.pl

Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1 and Velvetyna.